Fu Su
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Oncology 3
- Lymphatic System and Diseases 2
- Co-authors
- Donald B. Axworthy (2 shared papers)Paul L. Beaumier (2 shared papers)Alan R. Fritzberg (2 shared papers)J. M. Reno (1 shared paper)Louis Theodore (1 shared paper)Mark D. Hylarides (1 shared paper)Robert W. Mallett (1 shared paper)John M. Reno (1 shared paper)
- Journals
- Anti-Cancer Agents in Medicinal Chemistry (1 paper)Cancer Biotherapy and Radiopharmaceuticals (1 paper)International Journal of Oncology (1 paper)Journal of X-Ray Science and Technology (1 paper)Pathology & Oncology Research (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Fu Su
8 papers receiving 391 citations
Peers
Comparison fields: 5 of 53
- Radiology, Nuclear Medicine and Imaging 273
- Pathology and Forensic Medicine 65
- Oncology 75
- Cell Biology 33
- Neurology 24
Countries citing papers authored by Fu Su
This map shows the geographic impact of Fu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Su more than expected).
Fields of papers citing papers by Fu Su
This network shows the impact of papers produced by Fu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Su. The network helps show where Fu Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 197 | |
| 2 | Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin. | 2000 | 135 |
| 3 | 2015 | 26 | |
| 4 | 1996 | 15 | |
| 5 | 2019 | 13 | |
| 6 | 2015 | 13 | |
| 7 | 2016 | 9 | |
| 8 | 2019 | 2 |
About Fu Su
Fu Su is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cell Biology and Organic Chemistry, having authored 8 papers that have together received 410 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Biotin and Related Studies (2 papers), Lymphatic System and Diseases (2 papers), Axon Guidance and Neuronal Signaling (1 paper), Click Chemistry and Applications (1 paper) and Bone and Joint Diseases (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (273 citations), Pathology and Forensic Medicine (65 citations), Oncology (75 citations), Cell Biology (33 citations) and Neurology (24 citations). Fu Su has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Donald B. Axworthy, Paul L. Beaumier, Alan R. Fritzberg, J. M. Reno, Louis Theodore, Mark D. Hylarides, Robert W. Mallett, John M. Reno, Hazel B. Breitz and Paul L. Weiden. Their work appears in journals such as Anti-Cancer Agents in Medicinal Chemistry, Cancer Biotherapy and Radiopharmaceuticals, International Journal of Oncology, Journal of X-Ray Science and Technology and Pathology & Oncology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.